TBA The Biotechnology Initiative

The Voice of Bioscience in Ontario



TBI Event Sept. 21, 2007: Research to Revenue III

Promoting the growth of the biotechnology industry in Canada, TBI’s ‘From Research to Revenue III’ closed out another successful National Biotechnology Week, building on the success of its first two events.

Hosted by TBI, Western Greater Toronto Area Convergence Centre, and sponsored by YORK Biotech, and BioDiscovery Toronto, Research to Revenue continues to grow as a valuable learning and networking event for Canada’s life-science community.

Like in past years, CEO’s, CFO’s CSO’s and CMO’s attending were given the chance to network and discuss the industry and learn more about what it takes to be successful. This year’s session, hosted in Mississauga, ON, brought out some of the best and brightest minds in Canadian biotech business, from some of the industries biggest companies.

Panel discussions and workshops were just two of the ways attendees were able to interact and address key industry issues such as finance, product development, and commercialization. Discussions were split into three different tracks happening simultaneously.

Moderator Tim McCunn, lead the discussion in CEO track, with a focus on what the biotech industry can do to learn from other industries. The second CEO track featured Frederick Port, whose discussion centered on ways biotech companies can build value in its corporations. Other panelists in these discussions included Mark Chamberlain, Lorne Goldstein, Brian Hartman, Rob Peacock, and Richard Strafehl.

Dr. John Lawson and Pierre Bourassa headed up the conversation in the CFO track as panelists from various Canadian biotech companies including Adam Buckley, Bertrand F. Bolduc and Dr. Jean-Paul Castaigne discussed the origins of their companies, the obstacles they faced and the lessons they learned.

Dr. Alan Davis headed a panel that explored the pros and cons of doing clinical trials in Canada in the CSO/CMO track, while recognized expert in the field of clinical research and trial management Laurie Halloran took executives on a crash course in working through clinical development and finding clinical success in her workshop.